BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 10527639)

  • 1. Nature of the critical labile event that controls RB phosphorylation in the cyclic AMP-dependent cell cycle of thyrocytes in primary culture.
    Roger PP; Demartin S; Dumont JE
    Exp Cell Res; 1999 Nov; 252(2):492-8. PubMed ID: 10527639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic AMP-dependent phosphorylation of cyclin D3-bound CDK4 determines the passage through the cell cycle restriction point in thyroid epithelial cells.
    Paternot S; Coulonval K; Dumont JE; Roger PP
    J Biol Chem; 2003 Jul; 278(29):26533-40. PubMed ID: 12730225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
    Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP
    Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A requirement for cyclin D3-cyclin-dependent kinase (cdk)-4 assembly in the cyclic adenosine monophosphate-dependent proliferation of thyrocytes.
    Depoortere F; Van Keymeulen A; Lukas J; Costagliola S; Bartkova J; Dumont JE; Bartek J; Roger PP; Dremier S
    J Cell Biol; 1998 Mar; 140(6):1427-39. PubMed ID: 9508775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin D3 accumulation and activity integrate and rank the comitogenic pathways of thyrotropin and insulin in thyrocytes in primary culture.
    Van Keymeulen A; Bartek J; Dumont JE; Roger PP
    Oncogene; 1999 Dec; 18(51):7351-9. PubMed ID: 10602491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential utilization of cyclin D1 and cyclin D3 in the distinct mitogenic stimulations by growth factors and TSH of human thyrocytes in primary culture.
    Paternot S; Dumont JE; Roger PP
    Mol Endocrinol; 2006 Dec; 20(12):3279-92. PubMed ID: 16916940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New regulation mechanisms of cell cycle shown by analysis of thyroid cell proliferation stimulated by TSH and cyclic AMP].
    Roger P
    Bull Mem Acad R Med Belg; 2004; 159(5-6):396-405. PubMed ID: 15693550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respective roles of carbamylcholine and cyclic adenosine monophosphate in their synergistic regulation of cell cycle in thyroid primary cultures.
    Van Keymeulen A; Deleu S; Bartek J; Dumont JE; Roger PP
    Endocrinology; 2001 Mar; 142(3):1251-9. PubMed ID: 11181542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct specificities of pRb phosphorylation by CDK4 activated by cyclin D1 or cyclin D3: differential involvement in the distinct mitogenic modes of thyroid epithelial cells.
    Paternot S; Arsenijevic T; Coulonval K; Bockstaele L; Dumont JE; Roger PP
    Cell Cycle; 2006 Jan; 5(1):61-70. PubMed ID: 16294008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein synthesis during induction of DNA replication in thyroid epithelial cells: evidence for late markers of distinct mitogenic pathways.
    Lamy F; Roger P; Lecocq R; Dumont JE
    J Cell Physiol; 1989 Mar; 138(3):568-78. PubMed ID: 2647771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of the three Rb protein family members is a common step of the cAMP-, the growth factor, and the phorbol ester-mitogenic cascades but is not necessary for the hypertrophy induced by insulin.
    Coulonval K; Maenhaut C; Dumont JE; Lamy F
    Exp Cell Res; 1997 Jun; 233(2):395-8. PubMed ID: 9194502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes simplex virus type 1 infection imposes a G(1)/S block in asynchronously growing cells and prevents G(1) entry in quiescent cells.
    Ehmann GL; McLean TI; Bachenheimer SL
    Virology; 2000 Feb; 267(2):335-49. PubMed ID: 10662629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic AMP inhibits the proliferation of thyroid carcinoma cell lines through regulation of CDK4 phosphorylation.
    Rocha AS; Paternot S; Coulonval K; Dumont JE; Soares P; Roger PP
    Mol Biol Cell; 2008 Nov; 19(11):4814-25. PubMed ID: 18799615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
    Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S
    Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TSH and cAMP do not signal mitogenesis through Ras activation.
    Van Keymeulen A; Roger PP; Dumont JE; Dremier S
    Biochem Biophys Res Commun; 2000 Jun; 273(1):154-8. PubMed ID: 10873578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Pezcoller lecture: cancer cell cycles revisited.
    Sherr CJ
    Cancer Res; 2000 Jul; 60(14):3689-95. PubMed ID: 10919634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cAMP-dependent activation of mammalian target of rapamycin (mTOR) in thyroid cells. Implication in mitogenesis and activation of CDK4.
    Blancquaert S; Wang L; Paternot S; Coulonval K; Dumont JE; Harris TE; Roger PP
    Mol Endocrinol; 2010 Jul; 24(7):1453-68. PubMed ID: 20484410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential activity of TGF-beta2 on the expression of p27Kip1 and Cdk4 in actively cycling and contact inhibited rabbit corneal endothelial cells.
    Kim TY; Kim WI; Smith RE; Kay EP
    Mol Vis; 2001 Nov; 7():261-70. PubMed ID: 11723444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional regulation of D-type cyclins by insulin-like growth factor-I and serum in multiple myeloma cells.
    Glassford J; Rabin N; Lam EW; Yong KL
    Br J Haematol; 2007 Oct; 139(2):243-54. PubMed ID: 17897300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical role of cyclin D3 in TSH-dependent growth of thyrocytes and in hyperproliferative diseases of the thyroid gland.
    Motti ML; Boccia A; Belletti B; Bruni P; Troncone G; Cito L; Monaco M; Chiappetta G; Baldassarre G; Palombini L; Fusco A; Viglietto G
    Oncogene; 2003 Oct; 22(48):7576-86. PubMed ID: 14576819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.